We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Company to Promote Use of Cardiac PET

By HospiMedica staff writers
Posted on 16 Jun 2006
The Bracco Group (Milan, Italy), a developer of diagnostic imaging systems, and Integrated Medical Solutions, LLC (Sterling, VA, USA), a provider of positron emission tomography (PET) imaging centers in the United States, have formed a new company, Integrated Cardiac Solutions, LLC (ICS; Alexandria, VA, USA). More...
ICS will provide turnkey services that enable outpatient cardiology groups and heart centers to implement cardiac PET perfusion imaging technology for the detection of cardiovascular disease.

"The formation of ICS will lead an evolution in the field of cardiology,” said Carlo Medici, president and CEO of Bracco Diagnostics, Inc. (Princeton, NJ, USA). "Practices will now have an unprecedented opportunity to, first and foremost, offer expanded imaging services to their patients and, secondly, to improve the efficiency of their business. ICS and its wide array of services will be there to help them implement cardiac PET perfusion imaging every step of the way.”

Two recent clinical studies indicate that PET perfusion imaging is more accurate in the detection of coronary artery disease than the widely used single photon emission tomography (SPECT) perfusion imaging modality, particularly in women. Furthermore, the average time required for a cardiac PET perfusion test is about 30 minutes, versus three to four hours for the average cardiac SPECT perfusion scan, making cardiac PET more convenient for patients.

Cardiac PET perfusion imaging predominately uses the radionuclide rubidium-82, which can be derived from CardioGen-82 (rubidium Rb 82 generator), the only U.S Food and Drug Administration- (FDA)-approved generator-based cardiac PET perfusion agent. Over the past 18 months, the number of new CardioGen-82 sites has increased by nearly 90%. The adoption of cardiac PET in the outpatient setting is gaining favor among many cardiologists.

"I see ICS filling a missing piece in the rapidly emerging field of cardiac PET perfusion imaging. This venture will create a practical bridge, assisting practices in successfully implementing cardiac PET imaging as a significant and valued element in their patient management options,” stated Bill Abbott, vice president and general manager of nuclear medicine at Bracco Diagnostics.


Related Links:
Bracco Diagnostics
Integrated Cardiac Solutions

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.